» Articles » PMID: 9765300

A Transcriptional Coactivator, Steroid Receptor Coactivator-3, Selectively Augments Steroid Receptor Transcriptional Activity

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1998 Oct 9
PMID 9765300
Citations 69
Authors
Affiliations
Soon will be listed here.
Abstract

Estrogen receptors ERalpha and ERbeta are members of the family of nuclear hormone receptors and act as ligand-inducible transcriptional factors, which regulate the expression of target genes on binding to cognate response elements. We report here the characterization of steroid receptor coactivator-3 (SRC-3), a coactivator of nuclear receptor transcription that is a member of a family of steroid receptor coactivators that includes SRC-1 and transcription intermediate factor-2. SRC-3 enhanced ERalpha and progesterone receptor-stimulated gene transcription in a ligand-dependent manner, but stimulation of ERbeta-mediated transcription was not observed. Protein-protein interaction assays, including real-time interaction analyses with BIAcore, demonstrated that the affinity of the ERalpha interaction with SRC-3 was much higher than that observed for the ERbeta interaction with SRC-3. Mutational analysis suggests a potential interplay between the transactivation function-1 and -2 domains of ERalpha and SRC-3. Furthermore, an intrinsic transactivation function was observed in the C-terminal half of SRC-3. Finally, SRC-3 was differentially expressed in various tissues and, among several tumor cells examined, was most abundant in the nuclear fraction of MCF-7 breast cancer cells. Therefore, SRC-3, a third member of a family of steroid receptor coactivators, has a distinct tissue distribution and intriguing selectivity between ERalpha and ERbeta.

Citing Articles

TRIM33 Is a Co-Regulator of Estrogen Receptor Alpha.

Romo B, Karakyriakou B, Cressey L, Brauer B, Yang H, Warren A Cancers (Basel). 2024; 16(5).

PMID: 38473207 PMC: 10930732. DOI: 10.3390/cancers16050845.


Critical Roles of SRC-3 in the Development and Progression of Breast Cancer, Rendering It a Prospective Clinical Target.

Varisli L, Dancik G, Tolan V, Vlahopoulos S Cancers (Basel). 2023; 15(21).

PMID: 37958417 PMC: 10648290. DOI: 10.3390/cancers15215242.


AIB1/SRC-3/NCOA3 function in estrogen receptor alpha positive breast cancer.

Kiliti A, Sharif G, Martin M, Wellstein A, Riegel A Front Endocrinol (Lausanne). 2023; 14:1250218.

PMID: 37711895 PMC: 10498919. DOI: 10.3389/fendo.2023.1250218.


Chromatin Organization and Transcriptional Programming of Breast Cancer Cell Identity.

Bobbitt J, Seachrist D, Keri R Endocrinology. 2023; 164(8).

PMID: 37394919 PMC: 10370366. DOI: 10.1210/endocr/bqad100.


Significant Association of Estrogen Receptor-β Isoforms and Coactivators in Breast Cancer Subtypes.

Choi Y, Pollack S Curr Issues Mol Biol. 2023; 45(3):2533-2548.

PMID: 36975536 PMC: 10047005. DOI: 10.3390/cimb45030166.